Treace Medical Concepts (TMCI) Revenue (2020 - 2026)

Treace Medical Concepts has reported Revenue for 7 years, with the latest figure at $47.2 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 10.22% year-over-year to $47.2 million; the trailing twelve-month figure through Mar 2026 stood at $207.3 million (down 1.66% YoY), and the FY2025 full-year result was $212.7 million, up 1.59% from the prior year.
• Revenue for Q1 2026 stood at $47.2 million, down from $62.5 million in the prior quarter.
• The five-year high for Revenue was $68.7 million in Q4 2024, with the low at $29.0 million in Q1 2022.
• Historically, Revenue has averaged $47.0 million across 5 years, with a median of $47.2 million in 2026.
• Annual changes were most pronounced in 2022 — Revenue jumped 55.27% — and 2026, when it slipped 10.22%.
• Treace Medical Concepts' Revenue stood at $49.8 million in 2022, then gained by 25.0% to $62.2 million in 2023, then gained by 10.44% to $68.7 million in 2024, then declined by 9.01% to $62.5 million in 2025, then dropped by 24.51% to $47.2 million in 2026.
• The last three Revenue figures came in at $47.2 million (Q1 2026), $62.5 million (Q4 2025), and $50.2 million (Q3 2025), per Business Quant data.